05Aug
Defying gravity: US M&A H1 2019: Pharma chases innovation through deals
The need to replenish intellectual property has pushed the pharma industry to the highest-performing sector by M&A value. In the pharmaceuticals, medical and biotech sector, deal value in the first half of the year was up 142 percent to US$172...
By:
White & Case LLP
Related
At the end of 2019, courts in the UK decided that ethical veganism is a protected philosophical beli...
Read More >
The pharmaceutical, medical and biotech sector was number one by value, followed by technology, medi...
Read More >
In 2019, the Delaware courts issued a broad range of important decisions addressing various corporat...
Read More >
The social media revolution has changed the modern workplace in ways that could not possibly have be...
Read More >
The pandemic is driving the business world on-line in more ways. Arrangements for listed companies...
Read More >
Skadden partner Edward Micheletti, who heads the litigation practice of the firm’s Wilmington offic...
Read More >